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Abstract
Fgfrl1 (fibroblast growth factor receptor-like 1) is a transmembrane receptor that is essential for the development of the
metanephric kidney. It is expressed in all nascent nephrogenic structures and in the ureteric bud. Fgfrl1 null mice fail to
develop the metanephric kidneys. Mutant kidney rudiments show a dramatic reduction of ureteric branching and a lack of
mesenchymal-to-epithelial transition. Here, we compared the expression profiles of wildtype and Fgfrl1 mutant kidneys to
identify genes that act downstream of Fgfrl1 signaling during the early steps of nephron formation. We detected 56
differentially expressed transcripts with 2-fold or greater reduction, among them many genes involved in Fgf, Wnt, Bmp,
Notch, and Six/Eya/Dach signaling. We validated the microarray data by qPCR and whole-mount in situ hybridization and
showed the expression pattern of candidate genes in normal kidneys. Some of these genes might play an important role
during early nephron formation. Our study should help to define the minimal set of genes that is required to form a
functional nephron.
Citation: Gerber SD, Amann R, Wyder S, Trueb B (2012) Comparison of the Gene Expression Profiles from Normal and Fgfrl1 Deficient Mouse Kidneys Reveals
Downstream Targets of Fgfrl1 Signaling. PLoS ONE 7(3): e33457. doi:10.1371/journal.pone.0033457
Editor: Arun Rishi, Wayne State University, United States of America
Received September 10, 2011; Accepted February 14, 2012; Published March 14, 2012
Copyright:  2012 Gerber et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Swiss National Science Foundation (grant 31003A-127046) and the Swiss Foundation for Research on
Muscular Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: beat.trueb@dkf.unibe.ch
¤ Current address: Gurdon Institute, University of Cambridge, Cambridge, United Kingdom
Introduction
The mammalian kidney is a complex organ comprising
thousands of nephrons that are connected by a branched
collecting duct system [1]. The nephrons, the functional units of
the kidney, filter the blood through a basement membrane and
drain the filtrate via the collecting ducts to the bladder. In the
mouse, nephron development is initiated at E10.5 when a caudal
portion of the Wolffian duct near the hindlimbs bulges out and
forms the ureteric bud. Signals from the metanephric mesenchyme
induce the ureteric bud to branch in a stereotypical fashion to
form the highly branched collecting duct system. The ureteric bud
in turn releases signals that induce the metanephric mesenchyme
to condense around the tips of the ureteric bud and to form the
cap mesenchyme. Some cells of the cap mesenchyme undergo a
mesenchymal-to-epithelial transition and develop into renal
vesicles. These vesicles elongate, form s-shaped bodies and finally
mature into nephrons.
Several signaling pathways are involved in the development of
the nephron, including the Fgf/Fgfr, the Wnt/ß-catenin and the
Notch/Presenilin pathway. To induce nephron formation, Wnt9b
is secreted from the ureteric bud into the adjacent mesenchyme
where it binds to Frizzled receptors and activates the canonical ß-
catenin pathway [2,3]. In response, the metanephric mesenchyme
expresses the morphogens Fgf8 [4,5] and Wnt4 [6]. Fgf8 is
required for cell survival at different stages of nephrogenesis. Wnt4
induces cells from the cap mesenchyme to undergo the
mesenchymal-to-epithelial transition, which finally leads to the
formation of renal vesicles. Signaling by Notch and Presenilin is
then needed to pattern the proximal tubule of the nephron [7,8].
Recently, we have identified Fgfrl1 as a novel receptor that is
essential for nephron development [9]. Fgfrl1 belongs to the Fgfr
(fibroblast growth factor receptor) family of single transmembrane
receptors (for review see [10]). Its extracellular domain resembles
those of the classical Fgfrs in amino acid sequence and in that it
contains three Ig-like loops. However, the intracellular domain
differs from the classical receptors and does not possess any
tyrosine kinase activity [11,12]. The extracellular domain of Fgfrl1
interacts with heparin [13] and with Fgf ligands, primarily Fgf-2,
-3, -4, -8, and -22 [14]. The intracellular domain binds to
members of the Sprouty/Spred family that are known as negative
regulators of the growth factor-mediated activation of the Ras/
Raf/Erk signaling pathway [15]. During embryonic development,
Fgfrl1 is expressed in tissues of the musculoskeletal system,
including cartilage, bone and muscles [13], but also in the lung
and the kidneys [9]. Information about the function of Fgfrl1 was
gained from studies with mice, in which the Fgfrl1 gene was
deleted by targeted inactivation [16,17]. Fgfrl1 knock-out mice die
shortly after birth due to malformation of the diaphragm. The
mutant diaphragm muscle obviously is not strong enough to inflate
the lungs after birth. However, the most striking phenotype of the
Fgfrl1 deficient mice is the nearly complete absence of the
metanephric kidneys. Utilizing organ cultures and different
staining techniques, we demonstrated that Fgfrl1 deficiency leads
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to a dramatic reduction of ureteric branching and to a lack of
mesenchymal-to-epithelial transition in the nephrogenic mesen-
chyme [9]. As a result, the mutant embryos lack any renal vesicles
in their developing kidneys.
In the present study we used the DNA microarray profiling
technique to identify genes that act downstream of Fgfrl1 signaling
in the regulatory hierarchy of genes required for early nephron
development. We confirmed reduced expression of Wnt4 and Fgf8
in the kidneys of the Fgfrl1 deficient mice. In addition, we
identified more than 50 genes that are expressed at significantly
reduced levels in our mutant mice. Many of these genes are
involved in the Fgf/Fgfr, Wnt/ß-catenin, Bmp, Notch, and Six/
Eya/Dach signaling pathway.
Results
Fgfrl1 is expressed throughout metanephric kidney
development
In a previous study we have used polyclonal antibodies on thin
sections of E15.5 mouse kidneys to demonstrate that Fgfrl1 is
expressed in nephrogenic structures of the cortical zone, with
strong expression in renal vesicles, comma- and s-shaped bodies.
Weaker staining was found in the undifferentiated mesenchyme
and in the ureteric epithelium [9]. To verify these findings and to
gain more information about Fgfrl1 expression during kidney
development, we performed in situ hybridization on thin sections
(SISH) at three developmental stages (Fig. 1). At E12.5, Fgfrl1
mRNA was highly expressed in the metanephric mesenchyme and
in the ureteric bud. At E14.5, strong Fgfrl1 signal was detected in
nascent nephrons and in the metanephric mesenchyme. At E18.5,
Fgfrl1 signal was primarily found in tubules and nephrons. These
results demonstrate that Fgfrl1 is expressed in developing
nephrons and in the ureteric bud throughout kidney development,
thus confirming our previous results obtained by immunohisto-
chemistry.
Transcriptional profiling of Fgfrl1 deficient kidneys
To determine how the absence of Fgfrl1 signaling would affect
kidney development, we used Agilent DNA microarrays and
compared mRNA levels between wildtype and Fgfrl1 deficient
kidneys at E12.5. This time point was chosen because the first
phenotypic differences between wildtype and Fgfrl12/2 kidneys
are observed at E12.5 and because the first nephrogenic structures
become visible at this developmental stage. Our efforts led to the
identification of significant alterations in the transcriptome of the
Fgfrl1 deficient kidneys. Of the ,20,000 genes analyzed, 17 genes
showed an up-regulation $2 fold and 56 genes showed a down-
regulation $2 fold. None of the genes was up-regulated $3 fold
and only 14 genes were down-regulated $3 fold (Fig. 2). Among
the most strongly affected genes (indicated in the scatter plot of
Fig. 2 by gene symbols) were Wnt4, Fgf8, Lhx1 and Fgfrl1, which
had already been discovered as down-regulated markers in our
previous study [9]. Expression of Eya1 and Six2, which define the
uninduced mesenchyme, was barely affected by the absence of
Fgfrl1 (fold change 1.3 and 1.0, respectively). Thus, the microarray
data demonstrate the validity of our approach to identify mRNAs
that may act downstream of Fgfrl1 in the regulatory hierarchy of
genes required for nephron development.
Arbitrarily, we have chosen a minimal fold change .1.9 and a
p-value cutoff ,0.05 to generate a table of the most critical genes
that were down-regulated in Fgfrl1 deficient kidneys (Table 1, for a
list of all genes see GEO Series accession number GSE32013).
This table included all the genes that had previously been found to
be affected in the Fgfrl1 knock-out mouse (indicated in bold in
Tables 1 and 2). Besides Wnt4, Pax8, Fgf8 and Lhx1, our list
included 60 other genes that might contribute to the phenotype of
the Fgfrl1 knock-out mice. Among these hits are many genes that
have previously been described to be essential for normal kidney
development, such as Spry1 [18], Etv4 [19] and Itga8 [20], but
there are also several genes whose function in kidney development
has not been appreciated so far, including Fzd10, Frzb, Il17rd and
Dach1 (Table 1).
Validation by quantitative PCR
In order to confirm the results of the DNA microarray, we
quantified the mRNA levels of selected genes by RT-PCR. For this
purpose, we focused on hits that had yielded large differences
between wildtype and mutant kidneys. In this way, 29 down-
regulated genes, two control genes (Rps9 and Gapdh) and 3 up-
regulated genes were analyzed by qPCR (Table 2). For the
majority of the down-regulated hits, the qPCR results were found
Figure 1. Expression of Fgfrl1 in the developing mouse kidney.
Thin sections of embryonic mouse kidneys at E12.5, E14.5 and E18.5
were hybridized with a digoxigenin-labeled anti-sense RNA probe for
Fgfrl1. After hybridization, the sections were incubated with alkaline
phosphatase-conjugated antibodies against digoxigenin and the signal
was developed with BM purple. Expression of Fgfrl1 was observed in
the ureteric bud and in all nephrogenic structures. The inset of the
panel at E14.5 shows a control section hybridized with the sense probe
for Fgfrl1.
doi:10.1371/journal.pone.0033457.g001
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to be in good agreement with the microarray data, although the
differences (fold changes) observed by qPCR were larger than
those determined by microarray analysis. Only three genes (Dll1,
Msx2, Hey1) showed a minimal fold change ,1.9 by qPCR,
which had been selected as cutoff above.
In sharp contrast to the down-regulated transcripts, none of the
up-regulated transcripts (Tcfcp2l1, Cxcl12, Col1a1) could be
confirmed by qPCR as the fold changes observed by qPCR were
between 1.0 and 1.4. We may therefore conclude that the lack of
Fgfrl1 expression in the mutant kidneys was barely compensated
for by the up-regulation of other genes. In particular, the classical
receptors Fgfr1-Fgfr4 did not show altered expression in the
mutant kidneys.
For the microarray experiment, we had used E12.5 kidneys
because overt differences in the phenotype between wildtype and
Fgfrl1 deficient kidneys appear at this developmental stage.
However, changes in gene expression may occur prior to the
actual appearance of an altered phenotype and these changes may
or may not persist throughout kidney development. We therefore
analyzed the 29 down-regulated genes, the 3 up-regulated genes
and the two control genes also at three additional time points
during kidney development, one prior to and two after the stage
used for the microarray experiment (E11.5, E14.5, E16.5). These
data are also included in Table 2. Although some of the results
might be difficult to interpret, the majority of the genes can clearly
be grouped into two different categories. One category includes
genes whose fold changes show a bell-shaped curve during
embryonic development (e.g. Slc32a1, Pcp4, Wnt4, Lef1, Itga8,
Egr1). These genes might preferentially be required during the
initial stages of nephron development. The other category includes
genes whose fold changes steadily increase throughout develop-
ment (e.g. Fgf8, Lhx1, Uncx, Osr2, Dkk1, Clec18a, Dll1). It is
likely that these genes are particularly needed at later stages of
nephron development.
Validation by WISH
To further validate our data and to examine the spatial
expression pattern of the genes in the kidney, we performed whole-
mount in situ hybridization experiments (WISH). For this purpose,
we used E14.5 kidneys because samples at this stage revealed a
clearer expression pattern than samples at E12.5 due to the
increased size and the generally stronger gene expression level [9].
We primarily focused on genes, which had shown a difference .3
and which had not yet been annotated in the GUDMAP database
(www.gudmap.org). In total 12 genes were tested, including the
positive control Calb1 (Fig. 3). Calb1 revealed the expected
expression pattern in the ureteric bud and its derivatives, in both
the wildtype and the Fgfrl1 knock-out kidneys. In contrast,
expression of the other 11 genes was significantly reduced or even
absent in the Fgfrl1 deficient kidneys (Fig. 3). Likewise, expression
of the four nephrogenic marker genes Wnt4, Fgf8, Lhx1 and Pax8
that had been analyzed by WISH in our previous study was not
detected in the Fgfrl12/2 kidneys [9]. Thus, our in situ
hybridization data confirmed the microarray and the qPCR
results.
It is of interest to note that most of the genes detected by WISH
in the wildtype kidneys were expressed in the ureteric bud and/or
in developing nephrogenic structures, such as renal vesicles and s-
Figure 2. Identification of transcripts that are differentially expressed in Fgfrl1 deficient kidneys. The scatter plot shows average
normalized signal intensities from three independent experiments using E12.5 kidneys from wildtype and Fgfrl1 knock-out mice. Each dot represents
an individual gene. Dashed lines correspond to a fold change of 2. Transcripts that are down-regulated more than 3-fold are given by their gene
symbol.
doi:10.1371/journal.pone.0033457.g002
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Table 1. Genes with reduced expression in Fgfrl1 deficient kidneys.
Nr Gene Symbol Gene Description Gene ID pValue Fold Change Verification Method GUDMAP
1 Svopl SV2 related protein homolog-like 320590 0.0022 9.5 qPCR 8950;7412
2 Krt23 keratin 23 94179 0.0014 7.4 qPCR, WISH
3 Slc32a1 solute carrier family 32 member 1 22348 0.0015 7.0 qPCR, WISH 13958
4 Wnt4 wingless-related MMTV integration site 4 22417 0.0013 6.2 qPCR, WISH 8208;11295
5 Dkk1 dickkopf homolog 1 13380 0.0106 5.4 qPCR, WISH 9041
6 Egr1 early growth response 1 13653 0.0077 4.9 qPCR 6106;11301
7 Pcp4 immunoglobulin superfamily member 5 18546 0.0043 4.4 qPCR, WISH
8 Fgf8 fibroblast growth factor 8 14179 0.0015 4.4 qPCR, WISH
9 Lhx1 LIM homeobox protein 1 16869 0.0028 4.1 qPCR, WISH 5384;7928
10 Sp5 trans-acting transcription factor 5 64406 0.0185 3.7 WISH
11 Aldh1a1 aldehyde dehydrogenase family 1, subfamily A1 11668 0.0069 3.5 qPCR
12 Clec18a C-type lectin domain family 18 member A 353287 0.0055 3.4 qPCR, WISH
13 Fgfrl1 fibroblast growth factor receptor-like 1 116701 0.0035 3.1 qPCR, WISH
14 Bhlhb5 basic helix-loop-helix domain containing, class B5 59058 0.0002 3.0 5911
15 Hes5 hairy and enhancer of split 5 15208 0.0011 3.0 5928
16 Fzd10 frizzled homolog 10 93897 0.0180 2.9 8488
17 Gpx6 glutathione peroxidase 6 75512 0.0116 2.9
18 Alx1 ALX homeobox 1 216285 0.0104 2.8 5336
19 Lmcd1 LIM and cysteine-rich domains 1 30937 0.0001 2.7 6340
20 Cck cholecystokinin 12424 0.0247 2.7
21 Amph amphiphysin 218038 0.0158 2.7
22 Aldh1a7 aldehyde dehydrogenase family 1, subfamily A2 26358 0.0164 2.6
23 Galntl2 polypeptideN-acetylgalactosaminyltransferase-like 2 78754 0.0419 2.6
24 Jag1 jagged 1 16449 0.0269 2.5 qPCR 8532;11379
25 Hey1 hairy/enhancer-of-split related with YRPW motif 1 15213 0.0101 2.4 qPCR 5912
26 Dll1 delta-like 1 13388 0.0162 2.4 qPCR 11371
27 Plekhg6 pleckstrin homology domain-containing family G6 213522 0.0065 2.4
28 Akr1b7 aldo-keto reductase family 1, member B7 11997 0.0225 2.4
29 Greb1 gene regulated by estrogen in breast cancer protein 268527 0.0017 2.3 8529;8891
30 Cxcr4 chemokine (C-X-C motif) receptor 4 12767 0.0233 2.3 qPCR
31 Uncx UNC homeobox 22255 0.0060 2.3 qPCR 5729
32 Notum notum pectinacetylesterase homolog 77583 0.0061 2.3
33 Bmp2k BMP2 inducible kinase 140780 0.0434 2.3 qPCR
34 C1qdc2 family with sequence similarity 132, member A 67389 0.0101 2.3 9273
35 Ism1 isthmin 1 homolog 319909 0.0106 2.3
36 Lef1 lymphoid enhancer binding factor 1 16842 0.0071 2.3 qPCR 5539
37 Msx2 homeobox, msh-like 2 17702 0.0358 2.2 qPCR 5365
38 Pax8 paired box gene 8 18510 0.0202 2.2 qPCR, WISH 10742;11179
39 Etv4 ets variant gene 4 (E1A enhancer binding protein) 18612 0.0414 2.2 5486;12534
40 Bmp2 bone morphogenetic protein 2 12156 0.0020 2.2 qPCR 8949
41 B3galt5 beta-1,3-galactosyltransferase 5 93961 0.0131 2.2
42 Apom apolipoprotein M 55938 0.0127 2.1 10784
43 Cxcl14 chemokine (C-X-C motif) ligand 14 57266 0.0175 2.1 8425
44 Ankrd56 mus musculus ankyrin repeat domain 56 78088 0.0165 2.1
45 Frzb frizzled-related protein 20378 0.0102 2.1 qPCR, WISH
46 Naaa N-acylethanolamine acid amidase 67111 0.0077 2.1
47 Osr2 odd-skipped related 2 107587 0.0094 2.0 qPCR 6335;13623
48 Il17rd interleukin 17 receptor D 171463 0.0003 2.0 qPCR, WISH
49 Cpa2 carboxypeptidase A2, pancreatic 232680 0.0072 2.0
50 Lbx2 ladybird homeobox homolog 2 16815 0.0400 2.0 qPCR 6590
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shaped bodies. These genes included Wnt4, Fgf8, Lhx1 and Pax8
from the previous study and Spry1, Dach1, Dkk1, Il17rd, Frzb,
Krt23, Clec18a and Pcp4 from the present study (Fig. 3). In
contrast, expression of the transcription factor Sp5 and the amino
acid transporter Slc32a1 was rather diffuse, revealing no distinct
pattern. We may therefore conclude that the majority of the
differentially expressed genes identified by microarray analysis and
confirmed by WISH showed expression in renal vesicles and s-
shaped bodies, structures that are missing in our Fgfrl1 deficient
mice.
Discussion
In the present study we demonstrated that Fgfrl1 is expressed in
the ureteric bud and in all nephrogenic structures of wildtype
mice, including renal vesicles and comma- and s-shaped bodies.
Mice lacking the Fgfrl1 gene do not develop any nephrogenic
structures. A careful analysis of the kidney transcriptome from
wildtype and knock-out mice allowed us to identify more than 50
genes that act - directly or indirectly - downstream of Fgfrl1 in the
regulatory cascade of genes required for early nephron develop-
ment. Many of these genes appear to be involved in well-
established signaling pathways. However, it cannot be deduced
from our study whether all these genes are directly involved in the
same signaling pathway as Fgfrl1. Since Fgfrl1 deficient mice do
not develop any renal vesicles it is also possible that some of the
identified mRNAs lack in the Fgfrl1 null mice simply because they
are normal constituents of renal vesicles. To minimize such
‘‘secondary’’ effects, we analyzed kidneys at stage E12.5 where the
first nephrogenic structures become visible and where the first
phenotypic differences between wildtype and Fgfrl12/2 mice are
observed.
FGF signaling pathway
By virtue of our microarray approach, we found five down-
regulated genes (Fgf8, Spry1, Il17rd, Ism1, Etv4) that are involved,
directly or indirectly, in Fgf signaling. Fgf8 is essential for nephron
formation as mice lacking this gene do not progress beyond the
renal vesicle stage [4,5]. Interestingly, Fgf8 is one of the best
ligands for Fgfrl1 as demonstrated by a ligand dot blot assay [14].
Spry1 is an antagonist of Fgf signaling, which is crucial for normal
outgrowth of the ureteric bud as Spry12/2 embryos possess
supernumerous ureteric buds [18]. Il17rd (also termed Sef), Ism1
and Etv4 belong to the Fgf synexpression group [20–22]. This
group comprises several genes that show a similar spatiotemporal
expression pattern and that may serve a similar function during
development. Fgfrl1 [10], Il17rd [21], Spry2 and Spry4 [23] have
been reported to act as negative regulators of Fgf signaling. The
exact function of Fgfrl1 is not yet known, but we have speculated
that it might act as a decoy receptor, which sequesters Fgf ligands
away from the actively signaling receptors, or as a dominant
negative binding partner, which interacts with the other receptors
and inhibits transphosphorylation of the intracellular domains
[13]. If this were true, one would expect up-regulation of genes
that act downstream of FGF signaling, such as Fgfr1, Fgfr2 or
FGF8, resulting in increased numbers of ureteric buds and
nephrogenic structures. In sharp contrast, Fgfrl1 null mice have a
phenotype with renal dysplasia [9] very similar to mice with a
conditional disruption of Fgf8 [4,5] or a compound disruption of
the two receptors Fgfr1 and Fgfr2 [24]. This observation suggests
that Fgfrl1 might act as a positive regulator of FGF signaling
during kidney development and not as a decoy receptor.
WNT signaling pathway
The Wnt signaling pathway is often activated in concert with
Fgf signaling during developmental processes [25]. We found by
our microarray approach at least five genes that have been
implicated in Wnt signaling, namely Wnt4, Fzd10, Frzb, Lef1 and
Sp5. Among these hits, Wnt4 ranked at the top with a 6-fold
expression difference between wildtype and knock-out mice when
measured by microarray and 13-fold when verified by qPCR
experiments. Wnt4 is usually expressed in the metanephric
mesenchyme, where it induces the mesenchymal-to-epithelial
transition. Therefore mice lacking Wnt4 activity show a greatly
reduced number of nascent nephrogenic structures [6].
In a recent study, Valerius & McMahon [26] performed a
transcriptional profiling screen using Wnt4 deficient kidneys. The
authors identified 236 genes with differential expression levels
between wildtype and Wnt42/2 kidneys. Interestingly, several
genes exhibiting reduced expression in their study were also found
Table 1. Cont.
Nr Gene Symbol Gene Description Gene ID pValue Fold Change Verification Method GUDMAP
51 Spry1 sprouty homolog 1 24063 0.0183 2.0 WISH
52 Col13a1 collagen type XIII, alpha 1 12817 0.0034 2.0 8082
53 Dusp2 dual specificity phosphatase 2 13537 0.0003 2.0
54 Rbm20 RNA binding motif protein 20 73713 0.0107 2.0
55 Cdh4 cadherin 4 12561 0.0221 2.0 7763
56 Chrdl2 chordin-like 2 69121 0.0349 2.0
57 Gldc glycine decarboxylase 104174 0.0207 1.9
58 Itga8 integrin alpha 8 241226 0.0062 1.9 qPCR
59 Car4 carbonic anhydrase 4 12351 0.0006 1.9
60 Metap2 methionine aminopeptidase 2 56307 0.0234 1.9
61 Unc93a unc-93 homolog A 381058 0.0076 1.9
62 Gdnf glial cell line derived neurotrophic factor 14573 0.0445 1.9 qPCR
63 Dach1 dachshund 1 13134 0.0062 1.9 qPCR, WISH
64 Hs3st3b1 heparan sulfate(glucosamine)3-O-sulfotransferase3B1 54710 0.0342 1.9 11741
doi:10.1371/journal.pone.0033457.t001
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to be down-regulated in our study, such as Dll1, Pcp4, Dkk1,
Pax8, Fgf8, Lhx1, Hes5, Hey1 and Egr1. This result can be
explained by the fact that Fgfrl1 acts upstream of Wnt4 in the
cascade of regulatory genes as Fgfrl1 deficient mice lack Wnt4
expression in their kidney rudiments.
The other members of the Wnt signaling cascade that were
significantly down-regulated in our study appear to have diverse
functions. Fzd10 is one of the receptors for Wnt ligands. Frzb is a
secreted, frizzled-related receptor that interferes with Wnt
signaling. Lef1 is a transcription factor participating in Wnt
signaling. Canonical Wnt signaling leads to the stabilization of ß-
catenin, which - after translocation to the nucleus - interacts with
transcription factors of the Lef/Tcf family to induce expression of
target genes [27]. Sp5 is a member of the Sp1 transcription factor
family. It ranks among the ten best hits of our microarray analysis.
Fujimura et al. [28] presented evidence that Sp5 is involved in
Wnt signaling since constitutive activation of the Wnt/ß-catenin
pathway resulted in the up-regulation of Sp5 expression in the
mouse telencephalon.
Bmp signaling
With our microarray, we found reduced expression of Bmp2
and Bmp2k. The Bmps play a key role in the development of the
skeleton, but they are also involved in patterning of the
metanephric kidney [29]. Bmp2 is expressed in the distal renal
vesicle as shown by Georgas et al. [30]. The authors suggested that
Bmp2 might be involved - together with other factors - in the
fusion of the renal vesicle with the ureteric tip. Bmp2k is a serine/
threonine protein kinase whose expression is induced after
addition of Bmp2 to prechondroblastic cells in order to trigger
their differentiation [31]. However, the role of Bmp2k during
nephron formation has not yet been investigated.
Notch signaling pathway
Notch signaling is required to pattern the distal and proximal
tubule of the nephron [32]. In our microarray, the Notch ligands
Jag1 and Dll1 as well as the downstream effector Hey1 were down-
regulated. However, Hey1 and Dll1 showed only mild reduction
when validated by qPCR (1.4- and 1.7-fold, respectively), in
contrast to Jag1, whose expression was reduced 7.4-fold. Jag1 is
known to interact with Notch2 and other Notch receptors [33]. It
regulates ureteric budding and branching by crosstalk with Gdnf/
Ret signaling [34]. It is therefore likely that downregulation of Jag1
in the Fgfrl1 deficient kidneys reduces Notch signaling and hence
interferes with normal nephron development.
Six-Eya-Dach signaling pathway
Six (sine oculis), Eya (eyes absent) and Dach are transcription
factors that constitute the ‘‘retinal determination network’’, whose
loss inhibits eye development and whose forced expression leads to
ectopic eye formation [35]. It is believed that the three factors
form a complex that binds to the promoter region of target genes
to control eye formation in mammals and insects. Besides their
function in eye formation, Six1 and Eya1 are also involved in the
development of the metanephric kidneys of mammals [36] as
targeted deletion of either one of these genes leads to severe kidney
malformation. Targeted disruption of Dach1, however, does not
seem to have any obvious effect on kidney or eye formation,
although mice without Dach1 exhibit postnatal lethality [37].
In our gene array, Six1 and Eya1 were not differentially
expressed (fold change 1.1 and 1.3, respectively). This is in contrast
to Dach1, which was significantly down-regulated (qPCR 6.0-fold,
Table 2). It is therefore likely that Six1 and Eya1 act upstream,
while Dach1 acts downstream of Fgfrl1 in the same regulatory
network of genes that are required for kidney development. As a
matter of fact, the phenotypes of Fgfrl1, Eya1 and Six1 deficient
mice look intriguingly similar. All of them show kidney and bone
malformations [9,38,39]. In addition, Six1 and Fgfrl1 knock-out
mice exhibit defects in the diaphragm [16,40]. Dach1 is expressed
in developing nephrons, primarily in comma- and s-shaped bodies
[41]. This is consistent with our WISH experiments where a
prominent signal for Dach1 was found in the metanephric
mesenchyme surrounding the ureteric tips (Fig. 3). Brunskill et
al. [42] observed strong upregulation of Dach1 during nephron
formation, especially when the stage of the renal vesicle was
compared with that of the s-shaped body (46-fold). It is likely that
Fgfrl1 is involved in this upregulation since our Fgfrl1 deficient
kidneys show strongly reduced Dach1 expression.
Table 2. Verification of differential gene expression by qPCR.
Gene Fold change wt/ko qPCR Fold change wt/ko
E11.5 E12.5 E14.5 E16.5 array E12.5
Slc32a1 0.8 .20 13.4 11.7 7
Krt23 7.5 17.4 1.5 3.6 7.4
Pcp4 2.7 17 6 1 4.4
Wnt4 2.3 13.3 3.8 2.3 6.2
Pax8 1.5 9.6 3.9 4.7 2.2
Svopl 11.1 9.4 10.6 .20 9.5
Fgf8 3.2 9.2 16.4 .20 4.4
Il17rd 2.3 8.5 5.9 4.9 2
Lef1 2.4 8.2 0.8 2.1 2.3
Lhx1 0.7 7.7 12.7 .20 4.1
Jag1 2 7.4 5.7 3.9 2.5
Uncx 1.6 7 10.1 17.2 2.3
Itga8 3.1 6.9 2.6 2.1 1.9
Fgfrl1 .20 6.8 7.5 .20 3
Frzb 2.5 6.1 2.9 3.4 2.1
Dach1 1.7 6 4 5.1 1.9
Bmp2 0.8 5.2 7.9 6.3 2.2
Osr2 2.9 4.8 11.7 .20 2
Egr1 1 4.6 2.1 1.5 4.9
Aldh1a1 9.8 4 6.3 3.7 3.5
Gdnf 3.5 3 3.1 4.1 1.9
Cxcr4 1.7 3.4 3.7 3.1 2.3
Dkk1 2.5 3 13.1 .20 5.4
Clec18a 2.1 2.3 .20 .20 3.4
Lbx2 0.8 2.1 2.1 1.5 2
Bmp2k 1 2 1 1 2.3
Dll1 1.1 1.7 7.4 13.6 2.4
Msx2 0.4 1.6 1.2 0.7 2.2
Hey1 1.6 1.4 3.3 5 2.4
Tcfcp2l1 3.1 1.4 1.2 3.6 0.5
Cxcl12 2.2 1.3 0.7 1.2 0.5
Rps9 1.9 1.2 1.8 2.4 1.1
Gapdh 1 1 1 1 1
Col1a1 0.8 1 0.7 0.5 0.5
doi:10.1371/journal.pone.0033457.t002
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Conclusions
We have identified a number of genes that act downstream of
Fgfrl1 signaling in the regulatory hierarchy of genes required for
early nephron development. Several of these genes are involved in
Fgf/Fgfr, Wnt/ß-catenin, Bmp, Notch, and Six/Eya/Dach
signaling. The downregulation of these genes might be responsible
for the lack of nephrogenesis observed in Fgfrl1 knock-out mice.
For some of the identified genes, a potential involvement in the
development of the metanephric kidneys has not yet been
appreciated (e.g. Fzd10, Frzb, Il17rd and Dach1). Our study
should therefore help to define the minimal set of genes that is
required for normal nephron formation.
Materials and Methods
Animals
All animal work was conducted according to the relevant
national guidelines and was approved by the Amt fu¨r Land-
wirtschaft und Natur of Bern (approval number 69/09). The
Fgfrl1 deficient mice have previously been described [9].
Littermates of wildtype and Fgfrl1 knock-out mice were used for
all experiments. For an exactly timed pregnancy, the noon of the
day, at which a vaginal plug was detected, was considered as E0.5.
DNA Microarray analysis
Kidney rudiments were dissected in parallel from wildtype and
Fgfrl1 knock-out mice of stage E12.5. Total RNA was extracted
from pooled kidney rudiments (n = 6–9) with the GeneElute
miniprep kit from Sigma-Aldrich Co. The quality of the RNA was
assessed with an Agilent 2100 Bioanalyser (Agilent Technologies,
Palo Alto, CA, USA). Three individual RNA preparations from
wildtype mice and three individual RNA preparations from Fgfrl1
knock-out mice were separately transcribed into double stranded
cDNA in the presence of RNA poly-A controls (RNA Spike-In
Kit, Agilent 5188-5279). The cDNAs were transcribed with T7
polymerase into cRNA utilizing cyanine 3-CTP (Cy3) for knock-
out and cyanine 5-CTP (Cy5) for wildtype samples, respectively
(Agilent 5190-0444). No amplification step was performed. The
three pairs of fluorescently labeled cRNA were hybridized for 17 h
at 65uC to an Agilent gene expression array (Whole Mouse
Genome Microarray 4644 K, G4122F) according to the instruc-
tions of the manufacturer utilizing reagents from the Gene
Figure 3. Whole mount in situ hybridization (WISH) of selected marker genes in E14.5 kidneys. Kidneys from wildtype and Fgfrl1 knock-
out mice were hybridized with digoxigenin-labeled RNA probes and the probes were detected with alkaline phosphatase conjugated antibodies
against digoxigenin. All probes produced clear expression patterns in the wildtype kidneys. In contrast, the same probes did not display any pattern
in knock-out kidneys, with the exception of Calb1 that was included as a positive control. The white arrows indicate the kidney rudiments of the
knock-out embryos.
doi:10.1371/journal.pone.0033457.g003
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Expression Hybridization Kit (Agilent 5188-5242). The slides were
washed and scanned using an Agilent G2565BA microarray
scanner. Signals were extracted from images using the Agilent
Feature Extraction software version 10. Data analysis was
performed on the R platform for statistical computing with
packages from the Bioconductor project [43]. Gene annotation
and identifier conversions were retrieved from the Mouse Genome
Database (MGD, http://www.informatics.jax.org). All microarray
data were deposited in the GEO database and comply with
MIAME standards (accession number GSE32013).
Quantitative PCR analysis
Quantitative PCR was performed as previously described [9].
In brief, the RNA was transcribed into first strand cDNA with
reverse transcriptase from Moloney Murine Leukemia Virus. The
cDNAs were quantified by real time PCR on an ABI 7500
platform using the primer pairs listed in Table S1.
In situ hybridization
Whole-mount in situ hybridization (WISH) was performed as
described before [9]. Different hybridization probes were
generated by PCR utilizing cDNA prepared from E16.5 kidneys
and the primer pairs listed in Table S2.
In situ hybridization on thin sections (SISH) was performed
according to Koch et al. [44] with minor modifications. Sense and
anti-sense riboprobes for Fgfrl1 were prepared by reverse
transcription from the full-length cDNA cloned into the vector
pcDNA3.1 (+/2) using the digoxigenin RNA labeling kit from
Roche Diagnostics (Rotkreuz, Switzerland). Dissected kidneys
were fixed with paraformaldehyde (4% PFA in PBS, overnight at
4uC) and incubated in a sucrose solution (30% sucrose in PBS,
overnight at 4uC). Equilibrated samples were embedded in Tissue-
Tek, frozen on dry ice and cut to 12 mm sections. Cryosections
were fixed with PFA (4% in PBS, 20 min at RT) and digested with
proteinase K (10 mg/ml, 10 min at RT). After refixation (4% PFA,
20 min), sections were acetylated (0.25% acetic anhydride, 0.1 M
triethanolamine, pH 8.0, 10 min). Acetylated sections were
prehybridized in hybridization buffer (50% formamide, 46 SSC,
26 Denhardt’s solution, 5% dextran sulfate, 100 mg/ml yeast
tRNA, 5 h at RT) and hybridized with the Fgfrl1 probe (overnight
at 68uC with 1 mg/ml of the digoxigenin-labeled riboprobe). After
a series of washing steps (wash 1: 0.26SSC, 30 min at 60uC; wash
2: 50% formamide, 26 SSC, 30 min at RT; wash 3: 0.26 SSC,
10 min at RT; wash 4: 0.1 M maleic acid, 0.15 M NaCl, 0.1%
Tween-20, pH 7.4, 15 min at RT) the sections were blocked with
BSA (3% in Tris buffered saline, 2 h at RT) and incubated with
anti-digoxigenin antibodies (alkaline phosphatase-conjugated Fab
fragments from Roche, diluted 1:2000, overnight at 4uC). The
slides were rinsed and equilibrated with detection buffer (0.1 M
Tris, 0.1 M NaCl, 50 mM MgCl2, pH 9.5). Finally, the
hybridization signal was developed with BM Purple (Roche, 12–
24 h at RT) and the slides were photographed under an Olympus
BX-51 microscope.
Supporting Information
Table S1 Primers used for RT-PCR.
(DOC)
Table S2 Primers used for WISH. Underlined nucleo-
tides indicate restriction sites used for subcloning.
(DOC)
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